BD Joins National Patient Safety Foundation Corporate Council, Furthers Commitment to Safety
Will Collaborate with Healthcare Industry Stakeholders to Collectively Create Safer Healthcare Environments
FRANKLIN LAKES, N.J. and BOSTON, Nov. 13, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has joined the National Patient Safety Foundation (NPSF) Corporate Council. The membership will enable BD to work alongside the Foundation and its constituent groups, including healthcare providers, other service and product providers, and patient and family representatives to raise awareness of patient safety issues and create solutions that address them.
"Our drive to create a safer healthcare system is deeply rooted in BD's commitment to improving access and outcomes of healthcare," said Bill Kozy, Executive Vice President, BD. "We are honored to stand alongside the National Patient Safety Foundation in discussing the actions needed to improve patient safety, with a particular emphasis on ensuring safe preparation and administration of medications. In this mission, we recognize the need to improve clinical outcomes while simultaneously lowering the cost of care and are committed to creating solutions that do both."
"It is a pleasure to welcome BD as the newest member of the NPSF Corporate Council," said NPSF President Tejal K. Gandhi, MD, MPH, CPPS. "BD's engagement with us speaks volumes about its organization-wide commitment to safe patient care. We very much look forward to BD's insights and partnership as we strive together to deliver on the patient safety mission."
Making patient care safer is a common goal of NPSF and members of its Corporate Council, which allows for the sharing of ideas among stakeholders with diverse perspectives.
For more information on safe medication delivery, visit www.bd.com/us/medicationsafety.
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs nearly 30,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.
About the National Patient Safety Foundation
The National Patient Safety Foundation (NPSF) has been pursuing one mission since its founding in 1997 – to improve the safety of care provided to patients. As a central voice for patient safety, NPSF is committed to a collaborative, multi-stakeholder approach in all that it does. NPSF is an independent, not-for-profit 501(c)(3) organization. To learn more about the work of the National Patient Safety Foundation, please visit: www.npsf.org.
BD Public Relations
SOURCE BD (Becton, Dickinson and Company)
Released November 13, 2013